| dc.contributor.author | Dupont-Rouzeyrol, Myrielle | |
| dc.contributor.author | O’Connor, Olivia | |
| dc.contributor.author | Calvez, Elodie | |
| dc.contributor.author | et al. | |
| dc.date.accessioned | 2023-01-13T09:13:16Z | |
| dc.date.available | 2023-01-13T09:13:16Z | |
| dc.date.issued | 2016 | |
| dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313662/ | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12663/3305 | |
| dc.description.abstract | Dengue is the most prevalent arthropod-borne viral disease in tropical and subtropical countries. Every year, dengue virus (DENV) infections cause more than 50 million cases, 500,000 hospitalizations, and 12,500 deaths worldwide (1). DENV belongs to the genus Flavivirus and is transmitted by Aedes spp. mosquitoes. There are 4 distinct serotypes (DENV-1 to DENV-4), and infection with 1 serotype does not provide long-term, cross-protective immunity against the other 3 serotypes. | en_US |
| dc.language | English | en_US |
| dc.subject | Zika Research Project | en_US |
| dc.subject | Zika Virus | en_US |
| dc.subject | Zika Virus Infection | en_US |
| dc.subject | Dengue | en_US |
| dc.title | Co-infection with Zika and dengue viruses in 2 patients, New Caledonia, 2014 | en_US |
| eihealth.country | Others | en_US |
| eihealth.category | Epidemiology and epidemiological studies | en_US |
| eihealth.type | Research protocol information | en_US |
| eihealth.maincategory | Save Lives / Salvar Vidas | en_US |
| dc.relation.ispartofjournal | Emerging Infectious Diseases | en_US |
